Cargando…

Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin

OBJECTIVE: To characterize thyroid disturbances induced by interferon-alpha and ribavirin therapy in patients with chronic hepatitis C. INTRODUCTION: Interferon-alpha is used to treat chronic hepatitis C infections. This compound commonly induces both autoimmune and non-autoimmune thyroiditis. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danilovic, Debora Lucia Seguro, Mendes-Correa, Maria Cassia, Chammas, Maria Cristina, Zambrini, Heverton, Marui, Suemi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2011
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180154/ https://www.ncbi.nlm.nih.gov/pubmed/22012048 http://dx.doi.org/10.1590/S1807-59322011001000014

Ejemplares similares

Critical analysis of molecular tests in indeterminate thyroid nodules
por: Danilovic, Debora L. S., et al.
Publicado: (2018)

Thymic hyperplasia in Graves' disease
por: Danilovic, Debora Lucia Seguro, et al.
Publicado: (2011)

Diagnostic performance of thyroid ultrasound in Hürthle cell carcinomas
por: Santana, Nathalie Oliveira, et al.
Publicado: (2019)

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
por: Rashed, Yasser K., et al.
Publicado: (2020)

25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma
por: Danilovic, Debora Lucia Seguro, et al.
Publicado: (2016)

The End-Diastolic Velocity of Thyroid Arteries Is Strongly Correlated with the Peak Systolic Velocity and Gland Volume in Patients with Autoimmune Thyroiditis
por: Bianchini Höfling, Danilo, et al.
Publicado: (2017)

Interferon-Alpha Induced and Ribavirin Induced Thyroid Dysfunction in Patients with Chronic Hepatitis C
por: Nadeem, Amina, et al.
Publicado: (2010)

Active surveillance of papillary thyroid microcarcinomas in South America: Are we ready?
por: Danilovic, Debora Lucia Seguro, et al.
Publicado: (2019)

SAT-614 False-Positive in Measurement of Thyroglobulin in a Patient with Mixed Connective Tissue Disease
por: Maciel, Ana Alice, et al.
Publicado: (2019)

Evaluation of Downstream Regulatory Element Antagonistic Modulator Gene in Human Multinodular Goiter
por: Shinzato, Amanda, et al.
Publicado: (2015)

Safety and Efficacy of Low-Level Laser Therapy in Autoimmune Thyroiditis: Long-Term Follow-Up Study
por: Höfling, Danilo Bianchini, et al.
Publicado: (2018)

Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol
por: Zeng, Yan-Ming, et al.
Publicado: (2020)

Successful treatment of psychosis induced by interferon alpha and ribavirin with paliperidone: first case reported
por: Carrillo de Albornoz Calahorro, Carmen Maura, et al.
Publicado: (2019)

Ultrasound in cervical traumatic neuromas after neck dissection in thyroid carcinoma patients: descriptive analysis and diagnostic accuracy
por: Marcos, Vinicius Neves, et al.
Publicado: (2023)

SAT-567 Mutational Profile of Hurthle Cell Carcinomas: Recurrent Mutations in Wnt/β-catenin Pathway Genes
por: Santana, Nathalie, et al.
Publicado: (2019)

Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance
por: Pennisi, Manuela, et al.
Publicado: (2017)

The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study
por: Ferreira, Paulo Roberto Abrão, et al.
Publicado: (2014)

Association of Interferon-Alpha and Ribavirin-Induced Thyroid Dysfunction with Severity of Disease and Response to Treatment in Pakistani Asian Patients of Chronic Hepatitis C
por: Nadeem, Amina, et al.
Publicado: (2012)

Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer
por: Danilovic, Debora L. S., et al.
Publicado: (2018)

Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C
por: Martin, Carmen Sorina, et al.
Publicado: (2014)

Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
por: Gonçales, Fernando L, et al.
Publicado: (2010)

Suppurative thyroiditis due to aspergillosis: a case report
por: Marui, Suemi, et al.
Publicado: (2014)

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study
por: Huang, Yin-Qiu, et al.
Publicado: (2020)

Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
por: Abbas, Zaigham, et al.
Publicado: (2013)

Large Intestine Histopathology of Pegylated-Interferon-Alpha Plus Ribavirin Treated Chronic Hepatitis C Patients
por: Pantazis, Konstantinos D., et al.
Publicado: (2008)

The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C
por: Keshvari, Maryam, et al.
Publicado: (2016)

SAT-415 Clinical Performance of Thyroid-Stimulating Immunoglobulin for Graves′ Disease Diagnosis
por: Marui, Suemi, et al.
Publicado: (2020)

Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
por: Akram, Madiha, et al.
Publicado: (2011)

Efficacy and Long-Term Follow Up of Combination Therapy with Interferon Alpha and Ribavirin for Chronic Hepatitis C in Korea
por: Kim, Jie-Hyun, et al.
Publicado: (2006)

Natural leukocyte interferon alpha (Alfaferone) combined with ribavirin in the treatment of patients with HCV-related cirrhosis: our experience
por: Kozielewicz, D., et al.
Publicado: (2011)

Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro()
por: Weiss, Richard C., et al.
Publicado: (1989)

Cutaneous Sarcoidosis: An Uncommon Side Effect of Pegylated Interferon and Ribavirin Use for Chronic Hepatitis C
por: Martins, Elson Vidal, et al.
Publicado: (2009)

The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
por: Younossi, Zobair M, et al.
Publicado: (2012)

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens
por: Younossi, Zobair M., et al.
Publicado: (2016)

Circulating sCD14 Is Associated with Virological Response to Pegylated-Interferon-Alpha/Ribavirin Treatment in HIV/HCV Co-Infected Patients
por: Marchetti, Giulia, et al.
Publicado: (2012)

The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-α2β and Ribavirin
por: Tran, Huy A, et al.
Publicado: (2005)

MON-591 Thyroid Function and Autoimmunity Status after One and Three Months of Radioactive Iodine Therapy for Thyrotoxicosis
por: Irigoitia, Bruna, et al.
Publicado: (2019)

The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
por: Nishikawa, Hiroki, et al.
Publicado: (2012)

Negative Regulation of Hepatitis C Virus Specific Immunity Is Highly Heterogeneous and Modulated by Pegylated Interferon-Alpha/Ribavirin Therapy
por: Claassen, Mark A. A., et al.
Publicado: (2012)

Oxidative status and the response to pegylated-interferon alpha2a plus ribavirin in chronic genotype 4 HCV hepatitis
por: Ahmed, Mohammed Mahmound, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_udmlvak0ethggkaud9i8eu43i6